KF
BIIB icon

Krilogy Financial’s Biogen BIIB Stock Holding History

Krilogy Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
7,783
+193
+3% +$36.9K 0.05% 269
2026
Q1 		$1.34M Sell
7,590
-116
-2% -$21.4K 0.04% 291
2025
Q4 		$1.33M Sell
7,706
-1
-0% -$163 0.05% 285
2025
Q3 		$1.18M Buy
+7,707
New +$1.04M 0.04% 303
2021
Q3 		– Sell
-655
Closed -$227K – 269
2021
Q2 		$227K Buy
+655
New +$198K 0.02% 252
2018
Q4 		– Sell
-540
Closed -$191K – 189
2018
Q3 		$191K Buy
+540
New +$186K 0.04% 147
2018
Q2 		– Sell
-485
Closed -$133K – 203
2018
Q1 		$133K Buy
485
+107
+28% +$33.2K 0.03% 191
2017
Q4 		$120K Sell
378
-457
-55% -$147K 0.03% 203
2017
Q3 		$261K Buy
835
+505
+153% +$150K 0.07% 137
2017
Q2 		$90K Sell
330
-20
-6% -$5.29K 0.03% 230
2017
Q1 		$99K Hold
350
– – 0.03% 201
2016
Q4 		$99K Sell
350
-11
-3% -$3.26K 0.03% 201
2016
Q3 		$113K Sell
361
-86
-19% -$25.5K 0.04% 190
2016
Q2 		$108K Sell
447
-9
-2% -$2.37K 0.04% 191
2016
Q1 		$119K Buy
456
+356
+356% +$94K 0.05% 151
2015
Q4 		$31K Hold
100
– – 0.03% 173
2015
Q3 		$29K Buy
+100
New +$33K 0.01% 263

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Krilogy Financial's BIIB Position: Q2 2026 in Review

Krilogy Financial increased its Biogen (BIIB) stake by 2.5% in Q2 2026, buying an estimated $36.9K and bringing the position to 7,783 shares worth $1.68M. The position accounts for 0.05% of the portfolio, ranked #269.

Krilogy Financial first reported a position in BIIB in Q3 2015 and has held it in 17 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Krilogy Financial held 7,783 shares of Biogen worth $1.68M as of Q2 2026.
  • Krilogy Financial bought 193 Biogen shares in Q2 2026, an estimated $36.9K.
  • Biogen made up 0.05% of Krilogy Financial's portfolio in Q2 2026, its #269 holding.
  • Krilogy Financial first reported a position in Biogen in Q3 2015 and has held it in 17 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.